Catalyst Wire Dossier Catalyst Wire Dossier

Idursulfase-IT

idursulfase-IT · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Idursulfase-IT, covering 2018-12-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

See pricing